Jonhson & Johnson has announced that it is growing its medical devices division with the acquisition of software developer for surgery technologies, Orthotaxy.
acquisition
Orthotaxy’s technology is currently in early-stage development and includes differentiated robotic-assisted surgery solution for total and partial knee replacement.Johnson & Johnson aims to broaden the technology’s application for a range of orthopaedic surgery procedures.
Through the acquisition, Johnson & Johnson hopes to develop a robotic-assisted orthopaedic surgery solution that is cost-effective, time-efficient, and user-friendly in a variety of care settings.
The company will utilise Orthotaxy’s technology as part of a complete orthopaedic solution that uses enabling technologies to personalise procedures, optimise surgery and bring value to customers and patients.
Ciro Rӧmer, company group chairman of DePuy Synthes, the orthopaedics business of Johnson & Johnson, said: “Our goal is to bring to market a robotic-assisted surgery technology that is an integral part of a comprehensive orthopaedics platform, delivering value to patients, physicians and healthcare providers across the episode of care. The team at Orthotaxy has significant expertise and passion in developing this platform, and we aspire to bring to market a differentiated technology that helps improve clinical outcomes and increases patient satisfaction.”